Hiroyuki Kamao
10PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 11, 2025
Clinical Characteristics of Patients with Neovascular Age-Related Macular Degeneration and Responses to Anti-VEGF Therapy: Four-Group Stratification Based on Drusen and Punctate Hyperfluorescence.Hiroyuki Kamao, Katsutoshi Goto, Kenichi Mizukawa
|Sep 27, 2025
Impact of Punctate Hyperfluorescence Status on Treatment Outcomes of Faricimab Versus Aflibercept in Neovascular Age-Related Macular Degeneration.Hiroyuki Kamao, Katsutoshi Goto, Kenichi Mizukawa
|Jul 29, 2025
Punctate Hyperfluorescence as a Favorable Predictive Factor for Treatment Response Following a Switch to Brolucizumab for Patients with Aflibercept-Refractory Neovascular Age-Related Macular Degeneration.Hiroyuki Kamao, Katsutoshi Goto, Kenichi Mizukawa
|Mar 17, 2025
Treatment Outcomes of Simple and Complex Central Serous Chorioretinopathy.Hiroyuki Kamao, Katsutoshi Goto, Tatsuhiro Ouchi
|Feb 07, 2024
The Effect of a Loading Dose Regimen in the Switch to Brolucizumab for Patients with Aflibercept-Resistant nAMD.Hiroyuki Kamao, Erika Mitsui, Yuto Date
Pageof 2
